SO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Southern Co is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock's technical indicators, options sentiment, and financial performance suggest limited near-term upside potential. While the company has a strong dividend history and some positive catalysts, the regulatory uncertainties and declining financial metrics make it prudent to hold off on buying.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 46.202, and moving averages are converging, suggesting no strong trend. The stock is trading near a support level of 92.222, with resistance at 94.742. Overall, the technical indicators suggest a neutral to slightly bearish outlook.
Southern Co has a strong dividend history, recently increasing its annualized dividend to $3.04 per share, marking 25 consecutive years of growth.
Hedge funds have significantly increased their buying activity, up 213.85% over the last quarter.
Analysts like Citi and TD Cowen have maintained Buy ratings with price targets as high as $114.
Insiders are selling heavily, with a 776.96% increase in selling activity over the last month.
Regulatory uncertainties in Georgia and Alabama could impact future earnings.
Financial performance in Q4 2025 showed declining net income (-22.10% YoY), EPS (-22.92% YoY), and gross margin (-9.22% YoY).
Analysts like Morgan Stanley and Seaport Research have downgraded or maintained underweight ratings, citing regulatory risks and affordability concerns.
In Q4 2025, revenue increased by 10.09% YoY to $6.98 billion, but net income dropped by 22.10% YoY to $416 million. EPS also declined by 22.92% YoY to $0.37, and gross margin fell to 49.23%, down 9.22% YoY. These metrics indicate declining profitability despite revenue growth.
Analyst sentiment is mixed. Recent upgrades include Citi raising the price target to $114 and TD Cowen to $112, both with Buy ratings. However, Morgan Stanley and Seaport Research have downgraded or maintained underweight/neutral ratings, citing regulatory risks and affordability concerns. Price targets range from $92 to $114, with an average around $100.
